<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hipertensión &#187; Angiotensinas</title>
	<atom:link href="https://temas.sld.cu/hipertension/tag/angiotensina/feed/" rel="self" type="application/rss+xml" />
	<link>https://temas.sld.cu/hipertension</link>
	<description>Sitio web dedicado a la hipertensión en Cuba</description>
	<lastBuildDate>Fri, 06 Jun 2025 14:42:55 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>A Possible Interaction Between Systemic and Renal Angiotensinogen in the Control of Blood Pressure</title>
		<link>https://temas.sld.cu/hipertension/2013/06/03/a-possible-interaction-between-systemic-and-renal-angiotensinogen-in-the-control-of-blood-pressure/</link>
		<comments>https://temas.sld.cu/hipertension/2013/06/03/a-possible-interaction-between-systemic-and-renal-angiotensinogen-in-the-control-of-blood-pressure/#comments</comments>
		<pubDate>Mon, 03 Jun 2013 15:59:06 +0000</pubDate>
		<dc:creator><![CDATA[hipertension]]></dc:creator>
				<category><![CDATA[Propuestas del editor]]></category>
		<category><![CDATA[Angiotensinas]]></category>
		<category><![CDATA[Control de la presión arterial]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/hta/?p=2646</guid>
		<description><![CDATA[A Possible Interaction Between Systemic and Renal Angiotensinogen in the Control of Blood Pressure Por: Nirupama Ramkumar, Deborah Stuart, Jian Ying y Donald E. Kohan.  American Journal of Hypertension, Volume 26, Issue 4, Pp. 473-480. Angiotensinogen (AGT) is synthesized in the liver and proximal tubule. AGT overexpression at either site might increase blood pressure (BP). [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/hipertension/2013/06/03/a-possible-interaction-between-systemic-and-renal-angiotensinogen-in-the-control-of-blood-pressure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How important is it to control nocturnal hypertension with angiotensin II type 1 receptor blockers?</title>
		<link>https://temas.sld.cu/hipertension/2013/03/11/how-important-is-it-to-control-nocturnal-hypertension-with-angiotensin-ii-type-1-receptor-blockers/</link>
		<comments>https://temas.sld.cu/hipertension/2013/03/11/how-important-is-it-to-control-nocturnal-hypertension-with-angiotensin-ii-type-1-receptor-blockers/#comments</comments>
		<pubDate>Mon, 11 Mar 2013 09:33:30 +0000</pubDate>
		<dc:creator><![CDATA[hipertension]]></dc:creator>
				<category><![CDATA[Propuestas del editor]]></category>
		<category><![CDATA[Angiotensinas]]></category>
		<category><![CDATA[Control de la presión arterial]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/hta/?p=2444</guid>
		<description><![CDATA[Esta sección expone trabajos actuales, de carácter investigativo sobre la hipertensión arterial. How important is it to control nocturnal hypertension with angiotensin II type 1 receptor blockers? Por: Shin-ichiro Miura y Keijiro Saku.  Hypertension Research (2013) 36, 194–195. Better blood pressure (BP) control is associated with remarkable clinical benefits with regard to cardiovascular (CV) and [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/hipertension/2013/03/11/how-important-is-it-to-control-nocturnal-hypertension-with-angiotensin-ii-type-1-receptor-blockers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals</title>
		<link>https://temas.sld.cu/hipertension/2011/09/27/a-critical-appraisal-of-the-clinical-effectiveness-of-a-fixed-combination-of-valsartan-amlodipine-and-hydrochlorothiazide-in-achieving-blood-pressure-goals/</link>
		<comments>https://temas.sld.cu/hipertension/2011/09/27/a-critical-appraisal-of-the-clinical-effectiveness-of-a-fixed-combination-of-valsartan-amlodipine-and-hydrochlorothiazide-in-achieving-blood-pressure-goals/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 15:16:05 +0000</pubDate>
		<dc:creator><![CDATA[hipertension]]></dc:creator>
				<category><![CDATA[Propuestas del editor]]></category>
		<category><![CDATA[Amlodipino]]></category>
		<category><![CDATA[Angiotensinas]]></category>
		<category><![CDATA[Hidroclorotiazida]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/hta/?p=1008</guid>
		<description><![CDATA[A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals. [En idioma inglés] Por: Cheryl L Laffer y Fernando Elijovich. Integr Blood Press Control. 2011; 4: 1–5. Las recientes directrices para el tratamiento de la hipertensión se han centrado en la necesidad de medicamentos [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/hipertension/2011/09/27/a-critical-appraisal-of-the-clinical-effectiveness-of-a-fixed-combination-of-valsartan-amlodipine-and-hydrochlorothiazide-in-achieving-blood-pressure-goals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
